Santa Jeremy Ono, PhD, is the 28th President at the University of Cincinnati. After serving on an interim basis for two months, he was appointed to the presidency on Tuesday.

President Ono first arrived at UC in 2010, serving two years as the Senior Vice President for Academic Affairs and Provost. He is the first Japanese-American to serve as UC’s chief executive.

Ono also serves as Professor of Pediatrics within UC’s College of Medicine and Professor of Biology in the McMicken College of Arts and Sciences. His principal research interests focus on transcriptional regulation in the human immune system, mechanisms of mast cell dependent inflammation on the ocular surface and the immune component of age-related macular degeneration.

Ono’s first academic appointment was at the Johns Hopkins School of Medicine. While at Johns Hopkins, he won the American Diabetes Association Career Development Award and the Investigator Award from the National Arthritis Foundation.

Ono has served on the Medical Research Council’s Medical Advisory Board and College of Experts and the IMS and HAI study sections of the NIH. He consults widely for companies such as GSK, Cambridge Antibody Technologies plc (now part of Astra Zeneca), Johnson & Johnson, Santen Inc. and Oxagen plc. He is chief scientific officer of iCo Therapeutics Inc., of Vancouver.

Ono earned his PhD at McGill University and his BA at the University of Chicago. His training in Biochemistry and Molecular Biology at Harvard University was supported by a Helen Hay Whitney Foundation Fellowship.